Fawwad Qureshi Sells 6,111 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total value of $183,391.11. Following the sale, the chief financial officer directly owned 4,230 shares of the company’s stock, valued at approximately $126,942.30. The trade was a 59.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Stock Performance

Shares of TRUP opened at $29.65 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $46.98. The firm’s 50 day moving average price is $26.88 and its two-hundred day moving average price is $25.97. The firm has a market cap of $1.30 billion, a P/E ratio of 55.94, a PEG ratio of 2.04 and a beta of 1.39.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The company had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter in the prior year, the company earned $0.22 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. On average, analysts forecast that Trupanion, Inc. will post 0.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, August 12th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a report on Monday. Piper Sandler lowered Trupanion from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $45.00 to $32.00 in a research report on Wednesday. Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. Finally, Stifel Nicolaus upped their price target on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Thursday, August 20th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $39.20.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Renaissancere Holdings Ltd. acquired a new position in Trupanion during the second quarter worth $6,514,510,000. GSA Capital Partners LLP acquired a new stake in Trupanion in the second quarter valued at $1,394,000. Renaissance Technologies LLC lifted its stake in Trupanion by 550.0% in the first quarter. Renaissance Technologies LLC now owns 39,000 shares of the financial services provider’s stock valued at $999,000 after acquiring an additional 33,000 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Trupanion by 15.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider’s stock valued at $17,981,000 after acquiring an additional 95,064 shares during the period. Finally, Kopion Asset Management LLC grew its position in shares of Trupanion by 30.9% in the 2nd quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider’s stock valued at $12,955,000 after acquiring an additional 123,308 shares during the period.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.